Frank Schwöbel

Company: Immatics

Job title: Associate Director- Preclinical Pharmacology and Toxicology

Seminars:

Panel Discussion: Limitations of Humanised & PDX Models 1:45 pm

• How can we push these borders to include more supporting immune cells, dendritic cells, NK-cells? • Increasing longevity; CD34 humanised hyper immune-deficient mice can increase available study lengths but also increase the cost. Is there a middle ground? • Gaining data on persistence of cellular therapies without requiring additional miceRead more

day: Day One

Targeting of Tumor-Specific HLA Ligands with Bispecific T Cell-Engaging Receptor (TCER™) Molecules 9:30 am

• XPRESIDENT® to exploit the repertoire of tumor-associated antigens • Introduction into TCER™, Immatics’ TCR bispecific molecules • TCER™ in vivo dataRead more

day: Day One